Mario Luppi

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 554 citations · Full text

Medicine, Hematology, Oncology +16

Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease

David M. Good, Petra Zürbig, Àngel Argilés et al. · Molecular & Cellular Proteomics · 2010 · 538 citations · Full text

Life Sciences, Biochemistry, Nephrology +15

Dasatinib as first-line treatment for adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia

Robin Foà, Antonella Vitale, Marco Vignetti et al. · Blood · 2011 · 461 citations · Full text

Medicine, Hematology, Oncology +12

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11